|
|
Volumn 32, Issue 4, 2004, Pages 352-371
|
|
2003 Update of clinical practice guideline: Standards, Options and Recommendations for the use of FDG-PET in the management of gyneacologial and breast cancers;Recommandations pour la pratique clinique: Mise à jour 2003 des Standards, Options et Recommandations pour l'utilisation de la TEP-FDG dans la prise en charge des cancers gynécologiques et cancers du sein
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
TUMOR MARKER;
BREAST CANCER;
CANCER EPIDEMIOLOGY;
CANCER STAGING;
FEMALE;
FOLLOW UP;
GYNECOLOGIC DISEASE;
HUMAN;
IMAGING;
IMMUNOHISTOCHEMISTRY;
ISOTOPE LABELING;
MAMMOGRAPHY;
METASTASIS;
OVARY CANCER;
POSITRON EMISSION TOMOGRAPHY;
PRACTICE GUIDELINE;
REVIEW;
|
|
EID: 1942533021
PISSN: 12979589
EISSN: 17696682
Source Type: Journal
DOI: 10.1016/S1297958904000207 Document Type: Review |
|
Times cited : (7)
|
|
References (0)
|